Christoph Brackmann
Förmögenhet: 3 M $ per 2026-05-31
Förmögenhet: 3 M $ per 2026-05-31
Mr. Christoph Brackmann is a Chief Financial Officer at NovoCure Ltd. Mr. Brackmann was previously employed as a Senior Vice President-Finance by Moderna, Inc. and a Global Head-Investor Relations by Shire Plc.
He received his undergraduate degree from the University of Mannheim and an MBA from SDA Bocconi School of Management.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
NOVOCURE LTD. 0,16 % | 2026-04-06 | 188 144 ( 0,16 % ) | 3 M $ | 2026-05-31 |
| Företag | Position | Start |
|---|---|---|
| NOVOCURE LIMITED | Finansdirektör/CFO | 2025-01-01 |
| Företag | Position | Slut |
|---|---|---|
| MODERNA, INC. | Företagsledare/Principal | - |
| SHIRE | Offentlig kommunikationskontakt | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 5 |
|---|---|
Shire Plc
Shire Plc Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases | Health Technology |
University of Mannheim
University of Mannheim Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NovoCure Ltd.
NovoCure Ltd. Medical SpecialtiesHealth Technology Operates as a commercial-stage oncology company | Health Technology |
SDA Bocconi School of Management
SDA Bocconi School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Moderna, Inc.
Moderna, Inc. BiotechnologyHealth Technology Researches, develops, manufactures and commercializes mRNA-based respiratory & other virus vaccines, oncology and rare disease therapeutics | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån